Malaysia

Greenlight for two banned influenza vaccines to be used

Although Vaxigrip Tetra and SKYCellflu Quadrivalent were linked to deaths in South Korea, subsequent tests show that victims had underlying illnesses

Updated 6 years ago · Published on 03 Nov 2020 9:09AM

Greenlight for two banned influenza vaccines to be used
Health director-general Tan Sri Dr Noor Hisham Abdullah said the Korean Disease Control and Prevention Agency confirmed that there were no specific brands, manufacturers or vaccine cluster numbers that could be linked to the deaths. – The Vibes filepic, November 3, 2020

KUALA LUMPUR – Two influenza vaccine products, Vaxigrip Tetra and SKYCellflu Quadrivalent, which were temporarily discontinued, can now be used, said Health director-general Tan Sri Dr Noor Hisham Abdullah.

He said the Health Ministry, through the National Pharmaceutical Regulatory Agency (NPRA), has conducted a detailed risk assessment for the two vaccine brands based on information received from the Korean Disease Control and Prevention Agency (KDCA), local and global safety reports and other international regulatory bodies.

“As of Oct 31, the KDCA confirmed that the probability of linking the influenza vaccine as the cause of death, as reported (previously), is very low.

“The investigation report for 72 cases out of 83 death cases (11 cases still under investigation) shows that the cause of death is due to the existing illness suffered by the individuals concerned or other causes that have nothing to do with the given influenza vaccine,” he said on Facebook.

On October 28, the Health Ministry advised medical practitioners to temporarily stop the use of the two influenza vaccines following reports of deaths associated with the products in South Korea.

Dr Noor Hisham said the KDCA also confirmed that there were no specific brands, manufacturers or vaccine cluster numbers that could be linked to the deaths.

The Health Ministry, he said, had also evaluated the quality of the products and reviewed local and global reports on the adverse event following immunisation (AEFI)  covering the safety profile of all influenza vaccines, including both the vaccines.

He said a total of 1.5 million doses of influenza vaccine had been brought into Malaysia until October this year with the results of their evaluations, including the two brands of vaccines, to follow the prescribed quality standards.

“Further checks also found no death was reported following the administration of any influenza vaccine in Malaysia. The adverse effects that were reported are common adverse effects and have been documented,” he added. – Bernama, November 2, 2020

Spotlight

Malaysia

Geopolitical tensions must not derail regional economic integration - Anwar

Malaysia

Najib has been given a second chance. But where is the accountability to Malaysians?

By The Vibes Says

Malaysia

PAS joins BN in sitting out Sarawak polls

Malaysia

PAC to probe possible financial breaches, abuse of power in Sabah Pan Borneo project

Malaysia

Landowners cannot demolish unauthorised places of worship themselves, says Nga

By Alfian Z.M. Tahir

Malaysia

Najib’s house arrest: Differing views do not constitute treason – lawyer

Malaysia

Suspected criminal shot dead in exchange of fire with police in Perak

You may be interested

Malaysia

Ismail vows to resign if state government breaches undertaking to Tuanku Muhriz

Malaysia

Najib's house arrest to proceed despite residence not gazetted as prison, says Saifuddin

Malaysia

PAC to probe possible financial breaches, abuse of power in Sabah Pan Borneo project

Malaysia

MACC hands over wanted Chinese national to embassy

Malaysia

UNHCR suspends refugee registration, documentation services in Malaysia

Malaysia

Enforcement agencies, politicians top corruption perception list in Malaysia – survey

Malaysia

More than 100,000 personnel on standby for northeast monsoon

Malaysia

Mother and child killed in pre-dawn house fire in Batu Pahat